Literature DB >> 30039277

Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.

Francisco Schlottmann1,2, Daniela Molena3, Marco G Patti4,5.   

Abstract

The incidence of esophageal adenocarcinoma (EAC) has increased significantly in Western countries. The rising prevalence of gastroesophageal reflux disease (GERD) and obesity has played a major role in the increasing numbers of EAC. Approximately 10-15% of patients with GERD will develop Barrett's esophagus (BE). This metaplastic transformation is due to the chronic injury produced by repeated reflux episodes and involves genetic mutations that can lead to a malignant transformation. Ultimately, the development of EAC is characterized by the sequence BE metaplasia-dysplasia-invasive carcinoma.

Entities:  

Keywords:  Barrett’s esophagus; Esophageal adenocarcinoma; Gastroesophageal reflux disease; High-grade dysplasia; Low-grade dysplasia; Metaplasia

Mesh：

Year:  2018        PMID： 30039277     DOI： 10.1007/s13304-018-0564-y

Source DB:  PubMed          Journal:  Updates Surg        ISSN： 2038-131X


  37 in total

1.  Gastroesophageal reflux disease and mucosal injury with emphasis on short-segment Barrett's esophagus and duodenogastroesophageal reflux.

Authors:  S Oberg; M P Ritter; P F Crookes; M Fein; R J Mason; M Gadensytätter; C G Brenner; J H Peters; T R DeMeester
Journal:  J Gastrointest Surg       Date:  1998 Nov-Dec       Impact factor: 3.452

2.  Incidence of adenocarcinoma among patients with Barrett's esophagus.

Authors:  Frederik Hvid-Jensen; Lars Pedersen; Asbjørn Mohr Drewes; Henrik Toft Sørensen; Peter Funch-Jensen
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

3.  Global incidence of oesophageal cancer by histological subtype in 2012.

Authors:  Melina Arnold; Isabelle Soerjomataram; Jacques Ferlay; David Forman
Journal:  Gut       Date:  2014-10-15       Impact factor: 23.059

Review 4.  Epidemiology and risk factors for oesophageal adenocarcinoma.

Authors:  Côme Lepage; Antoine Drouillard; Jean-Louis Jouve; Jean Faivre
Journal:  Dig Liver Dis       Date:  2013-02-28       Impact factor: 4.088

5.  Mechanisms of acid injury to rabbit esophageal epithelium. Role of basolateral cell membrane acidification.

Authors:  N A Tobey; R C Orlando
Journal:  Gastroenterology       Date:  1991-11       Impact factor: 22.682

6.  Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett's esophagus.

Authors:  G Sarosi; G Brown; K Jaiswal; L A Feagins; E Lee; T W Crook; R F Souza; Y S Zou; J W Shay; Stuart Jon Spechler
Journal:  Dis Esophagus       Date:  2008       Impact factor: 3.429

7.  ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.

Authors:  Nicholas J Shaheen; Gary W Falk; Prasad G Iyer; Lauren B Gerson
Journal:  Am J Gastroenterol       Date:  2015-11-03       Impact factor: 10.864

8.  Factors Associated With Progression of Barrett's Esophagus: A Systematic Review and Meta-analysis.

Authors:  Rajesh Krishnamoorthi; Siddharth Singh; Karthik Ragunathan; Kavel Visrodia; Kenneth K Wang; David A Katzka; Prasad G Iyer
Journal:  Clin Gastroenterol Hepatol       Date:  2017-12-02       Impact factor: 11.382

9.  Trends in esophageal adenocarcinoma incidence and mortality.

Authors:  Chin Hur; Melecia Miller; Chung Yin Kong; Emily C Dowling; Kevin J Nattinger; Michelle Dunn; Eric J Feuer
Journal:  Cancer       Date:  2012-12-11       Impact factor: 6.860

10.  Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus.

Authors:  D C Whiteman; S Sadeghi; N Pandeya; B M Smithers; D C Gotley; C J Bain; P M Webb; A C Green
Journal:  Gut       Date:  2007-10-11       Impact factor: 23.059
View more
  7 in total

Review 1.  Does anti-reflux surgery disrupt the pathway of Barrett's esophagus progression to cancer?

Authors:  Sebastian F Schoppmann; Ivan Kristo; Martin Riegler
Journal:  Transl Gastroenterol Hepatol       Date:  2018-12-05

2.  Intestinal Stem Cell Marker ASCL2 is a Novel Prognostic Predictor in Esophageal Adenocarcinoma.

Authors:  Yukiko Shibahara; Osvaldo Espin-Garcia; James Conner; Jessica Weiss; Mathieu Derouet; Jonathan Allen; Frances Allison; Sangeetha Kalimuthu; Jonathan C Yeung; Gail E Darling
Journal:  Cureus       Date:  2022-01-07

3.  Molecular mechanism, regulation, and therapeutic targeting of the STAT3 signaling pathway in esophageal cancer (Review).

Authors:  Rui-Jie Ma; Chao Ma; Kang Hu; Meng-Meng Zhao; Nan Zhang; Zhi-Gang Sun
Journal:  Int J Oncol       Date:  2022-07-20       Impact factor: 5.884

4.  IL-33 Participates in the Development of Esophageal Adenocarcinoma.

Authors:  Jia Liu; Lei Liu; Yang Su; Yi Wang; Yuchun Zhu; Xiaobin Sun; Yuanbiao Guo; Jing Shan
Journal:  Pathol Oncol Res       Date:  2022-08-30       Impact factor: 2.874

5.  APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett's-associated esophageal adenocarcinomas.

Authors:  Farah Ballout; Heng Lu; Lei Chen; Kannappan Sriramajayam; Jianwen Que; Zhipeng Meng; Timothy C Wang; Silvia Giordano; Alexander Zaika; Oliver McDonald; Dunfa Peng; Wael El-Rifai
Journal:  J Exp Clin Cancer Res       Date:  2022-09-01

6.  Tongue diagnosis indices for gastroesophageal reflux disease: A cross-sectional, case-controlled observational study.

Authors:  Tzu-Chan Wu; Cheng-Nan Lu; Wen-Long Hu; Keng-Liang Wu; John Y Chiang; Jer-Ming Sheen; Yu-Chiang Hung
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

7.  Self-Reported Gastrointestinal Symptoms Two To Four Years After Bariatric Surgery. A Cross-Sectional Study Comparing Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy.

Authors:  Brit Thorsen; Kari Hanne Gjeilo; Jorunn Sandvik; Turid Follestad; Hallvard Græslie; Siren Nymo
Journal:  Obes Surg       Date:  2021-08-10       Impact factor: 4.129
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.